Rise in demand for early diagnosis is driving the genomics personalized health market size. Personalized genomics is essential for early screening, diagnosis, and individualized treatment as 80% of rare diseases have genetic origins. WILMINGTON, Del.
, July 26, 2024 /PRNewswire/ -- The global genomics personalized health market is projected to attain a valuation of US$ 33 billion by 2034, advancing at a CAGR of 12.2% in the forthcoming decade, as per a recent report published by Transparency Market Research. The genomics personalized health market is rapidly evolving, fueled by cutting-edge technological advancements and an increasing focus on individualized healthcare.
One of the key drivers of this market is the advent of next-generation sequencing (NGS) technologies, which have drastically reduced the cost and time required for sequencing the human genome. This has made genomic data more accessible, enabling healthcare providers to tailor treatments to the genetic profiles of individual patients. The market is also benefitting from advancements in bioinformatics and computational biology.
These fields are essential for managing and interpreting the vast amounts of data generated by genomic studies. Access Your Sample PDF Brochure: https://www.transparencymarketresearch.
com/sample/sample.php?flag=S&rep_id=12197 Artificial intelligence (AI) and machine learning (ML) are being increasingly integrated into genomics, enhancing the ability to identify genetic markers for disease.